CN102657818B - 一种治疗输液性静脉炎的药物及制备方法 - Google Patents
一种治疗输液性静脉炎的药物及制备方法 Download PDFInfo
- Publication number
- CN102657818B CN102657818B CN2012101482322A CN201210148232A CN102657818B CN 102657818 B CN102657818 B CN 102657818B CN 2012101482322 A CN2012101482322 A CN 2012101482322A CN 201210148232 A CN201210148232 A CN 201210148232A CN 102657818 B CN102657818 B CN 102657818B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- portions
- medicine
- hirudo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 42
- 208000001297 phlebitis Diseases 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 229940079593 drug Drugs 0.000 title abstract description 12
- 238000001802 infusion Methods 0.000 title abstract description 8
- 241000628997 Flos Species 0.000 claims description 19
- 241000237903 Hirudo Species 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 13
- 241000407170 Curcuma Species 0.000 claims description 12
- 235000014375 Curcuma Nutrition 0.000 claims description 12
- 241000245240 Lonicera Species 0.000 claims description 12
- 239000004615 ingredient Substances 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 238000003809 water extraction Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 238000012545 processing Methods 0.000 claims description 6
- 239000000341 volatile oil Substances 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 238000005469 granulation Methods 0.000 claims description 3
- 230000003179 granulation Effects 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 17
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 206010061218 Inflammation Diseases 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 238000001990 intravenous administration Methods 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 2
- 230000017423 tissue regeneration Effects 0.000 abstract description 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 241000545744 Hirudinea Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241000972672 Phellodendron Species 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 230000001338 necrotic effect Effects 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 22
- 210000004369 blood Anatomy 0.000 description 21
- 210000003462 vein Anatomy 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- 102000007625 Hirudins Human genes 0.000 description 2
- 108010007267 Hirudins Proteins 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229940006607 hirudin Drugs 0.000 description 2
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- CWVRJTMFETXNAD-BMNNCGMMSA-N (1s,3r,4s,5r)-3-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid Chemical compound O[C@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-BMNNCGMMSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 208000006193 Pulmonary infarction Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000002565 arteriole Anatomy 0.000 description 1
- 229960004099 azithromycin Drugs 0.000 description 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229960000479 ceftriaxone sodium Drugs 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- FDRNWTJTHBSPMW-GNXCPKRQSA-L disodium;(6r,7r)-7-[[(2e)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound [Na+].[Na+].S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)/C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(=O)C([O-])=NN1C FDRNWTJTHBSPMW-GNXCPKRQSA-L 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 229940093181 glucose injection Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940090044 injection Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- KRZBCHWVBQOTNZ-DLDRDHNVSA-N isochlorogenic acid Natural products O[C@@H]1[C@H](C[C@@](O)(C[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O)OC(=O)C=Cc3ccc(O)c(O)c3 KRZBCHWVBQOTNZ-DLDRDHNVSA-N 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 230000007575 pulmonary infarction Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000009146 rhinoscleroma Diseases 0.000 description 1
- 238000012428 routine sampling Methods 0.000 description 1
- 239000008354 sodium chloride injection Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 231100000456 subacute toxicity Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 201000005060 thrombophlebitis Diseases 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 210000004026 tunica intima Anatomy 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101482322A CN102657818B (zh) | 2012-05-10 | 2012-05-10 | 一种治疗输液性静脉炎的药物及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101482322A CN102657818B (zh) | 2012-05-10 | 2012-05-10 | 一种治疗输液性静脉炎的药物及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102657818A CN102657818A (zh) | 2012-09-12 |
CN102657818B true CN102657818B (zh) | 2013-11-13 |
Family
ID=46767486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012101482322A Active CN102657818B (zh) | 2012-05-10 | 2012-05-10 | 一种治疗输液性静脉炎的药物及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102657818B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104001140A (zh) * | 2014-06-10 | 2014-08-27 | 贾爱玲 | 一种治疗picc静脉炎软膏及其制备方法 |
CN105770534A (zh) * | 2016-03-31 | 2016-07-20 | 山东大学齐鲁医院 | 用于治疗输液性静脉炎的外用药物 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1151875A (zh) * | 1995-12-14 | 1997-06-18 | 北京海尔富药业有限公司 | 治疗脑血栓病及血栓性静脉炎的中成药“克栓”制剂及其制备方法 |
CN1390597A (zh) * | 2002-07-22 | 2003-01-15 | 齐正新 | 一种用于治疗血栓闭塞性脉管炎的川芎制剂及其配方 |
CN102008684A (zh) * | 2010-11-14 | 2011-04-13 | 贾荣娟 | 一种治疗ⅳ级化疗性静脉炎的中药组合物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003277281A (ja) * | 2002-03-20 | 2003-10-02 | Kumamoto Technology & Industry Foundation | 静脈炎の予防及び治療のための医薬 |
-
2012
- 2012-05-10 CN CN2012101482322A patent/CN102657818B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1151875A (zh) * | 1995-12-14 | 1997-06-18 | 北京海尔富药业有限公司 | 治疗脑血栓病及血栓性静脉炎的中成药“克栓”制剂及其制备方法 |
CN1390597A (zh) * | 2002-07-22 | 2003-01-15 | 齐正新 | 一种用于治疗血栓闭塞性脉管炎的川芎制剂及其配方 |
CN102008684A (zh) * | 2010-11-14 | 2011-04-13 | 贾荣娟 | 一种治疗ⅳ级化疗性静脉炎的中药组合物 |
Non-Patent Citations (1)
Title |
---|
JP特开2003-277281A 2003.10.02 |
Also Published As
Publication number | Publication date |
---|---|
CN102657818A (zh) | 2012-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105456989A (zh) | 消除疼痛的中药及其制备方法 | |
CN102631531B (zh) | 一种治疗搔痒型足底疔的中药洗剂制备方法 | |
CN103182019B (zh) | 治疗复发性口腔溃疡的中药组合物 | |
CN102861287B (zh) | 一种治疗湿热下注淤血型糖尿病足的中药组合物及其制备方法 | |
CN102631572B (zh) | 一种治疗出血型足底疔的中药洗剂制备方法 | |
CN101683441A (zh) | 一种活血解瘀中药组合物 | |
CN101244204B (zh) | 治疗痔疮的栓剂 | |
CN102357203B (zh) | 一种治疗烧烫伤的香榆烫伤膏 | |
CN102657818B (zh) | 一种治疗输液性静脉炎的药物及制备方法 | |
CN103768526A (zh) | 一种治疗痔疮的外用药膏 | |
CN102743556B (zh) | 一种治疗出血型霉菌性阴道炎中药洗剂的制备方法 | |
CN103599263B (zh) | 一种用于痔疮的中药及其制备方法 | |
CN102940757B (zh) | 治疗糖尿病足的药物组合物 | |
CN104189184A (zh) | 一种治疗痔疮的中药温敏凝胶剂 | |
CN103623122B (zh) | 一种用于痔疮的中药及其制备方法 | |
CN102940693A (zh) | 治疗糖尿病足的药物组合物 | |
CN104606446A (zh) | 一种治疗创伤后急性脓胸的胸腔冲洗液 | |
CN102552410B (zh) | 一种治疗高血压疾病药物的制备方法 | |
CN112641917A (zh) | 一种滇南血栓丸的制备方法 | |
CN106389598B (zh) | 一种治疗紫癜的中药组合物 | |
CN101904929A (zh) | 一种治疗牛皮癣的药剂及制备方法 | |
CN104983978A (zh) | 治疗烧伤的外用药物组合物、治疗烧伤的外用药膏及其制作方法 | |
CN109045204A (zh) | 一种治疗烧伤和烫伤的中药液及其制备方法 | |
CN104721290B (zh) | 一种防治足部疾病泡脚制剂及其制备方法 | |
CN102000144B (zh) | 用于治疗痔疮的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: RUDONG YANCHUAN WATER SERVICE CO., LTD. Free format text: FORMER OWNER: ZHANG LI Effective date: 20141211 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 262500 WEIFANG, SHANDONG PROVINCE TO: 226400 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141211 Address after: The new road Chahe town 226400 Jiangsu County of Rudong province No. 11 Patentee after: Rudong County Yan Chuan Water Service Co.,Ltd. Address before: 262500 Shandong city of Weifang province Qingzhou City Linglong Mountain Road No. 4138 Weifang Yidu Central Hospital Patentee before: Zhang Li |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200907 Address after: The new road Chahe town of Rudong County in Jiangsu province Nantong City, No. 11, 226400 Patentee after: Rudong Yanchuan Property Management Co.,Ltd. Address before: The new road Chahe town 226400 Jiangsu County of Rudong province No. 11 Patentee before: Rudong County Yan Chuan Water Service Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20230106 Address after: No. 1, Zone 7, Nantong Galaxy Industrial Park, Rudong County, Nantong, Jiangsu 226400 Patentee after: NANTONG QIANQIANHUI NEED CHEMICAL CO.,LTD. Address before: 226400 No.11, Xinjian Road, Chahe Town, Rudong County, Nantong City, Jiangsu Province Patentee before: Rudong Yanchuan Property Management Co.,Ltd. |
|
TR01 | Transfer of patent right |